eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hypertriglyceridemia |
| Comorbidity | C0011860|type 2 diabetes mellitus |
| Sentences | 6 |
| PubMedID- 24876549 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridemia in patients with type 2 diabetes mellitus. |
| PubMedID- 25617537 | This literature review discusses the safety on glucose metabolism of n-3 pufa supplementation in the treatment of hypertriglyceridemia in subjects with type 2 diabetes mellitus. |
| PubMedID- 23417910 | Severe hypertriglyceridaemia in type 2 diabetes mellitus: beneficial effect of continuous insulin infusion. |
| PubMedID- 25573251 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridaemia in patients with type 2 diabetes mellitus20. |
| PubMedID- 21510110 | Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. |
| PubMedID- 23853615 | Raised tg levels, small low density lipoprotein-cholesterol (ldl-c) particles, and low hdl-c (22)); low hdl-c was a component of mets only in the presence of hypertriglyceridemia in patients with type 2 diabetes mellitus (10). |
Page: 1